2024-11-0920220041-134510.1016/j.transproceed.2021.08.0572-s2.0-85118336806http://dx.doi.org/10.1016/j.transproceed.2021.08.057https://hdl.handle.net/20.500.14288/11594Liver transplantation is the final treatment option for end-stage liver disease and acute liver failure, although availability of donor organs is a major limitation. The large gap between the growing list of patients awaiting liver transplantation and the scarcity of donor organs has fueled efforts to maximize the existing donor pool and identify new avenues. We treated a 13-year-old boy who had acute liver failure, due to Wilson's disease, with transplantation of a liver from a deceased liver donor with a calcified hydatid cyst. After 3 years of follow-up, liver function tests remained normal, hydatid cyst serology was negative, and no hydatid cyst or other problems were observed.ImmunologySurgeryTransplantationConference proceeding1873-26237518635000414347